medigraphic.com
SPANISH

Ginecología y Obstetricia de México

Federación Mexicana de Ginecología y Obstetricia, A.C.
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2015, Number 01

<< Back Next >>

Ginecol Obstet Mex 2015; 83 (01)

Medical treatment of the uterine miomas in perimenopausal patients

Olvera-Maldonado AJ, Martínez-Uribe A, Rendón-Macías ME, Sangines-Martínez A
Full text How to cite this article

Language: Spanish
References: 10
Page: 41-47
PDF size: 347.77 Kb.


Key words:

Uterine leiomyomatosis, medroxyprogesterone acetate, abnormal uterine bleeding, hysterectomy, perimenopause.

ABSTRACT

Background: Leiomyomas are the most common benign tumors of the uterus, frequently associated with abnormal uterine bleeding. Medroxyprogesterone (MP) acetate it is a therapeutic alternative.
Objective: To determine the efficacy of the medroxyprogesterone for abnormal uterine bleeding associated with leiomyomatosis in perimenopause women.
Methods: An observational, prospective, longitudinal study. We selected 31 patients with uterine myomas and abnormal uterine bleeding. Two years monthly doses of 150 mg of MP were given. If the bleeding did not stop at six months of treatment or increased a hysterectomy was performed.
Results: Two (6.4%) patients abandoned the treatment after a first doses; 21 (67.7%) completed the treatment without uterine bleeding (efficacy observed of 72.4%; CI 95% 54.4 to 90.4%, intention to treat efficacy 67.7%, CI95% 49.6 to 86.8%). Eight (25.8%) patients persisted with uterine bleeding before 6 months of treatment and a hysterectomy was performed. There was no severity secondary effect informed.
Conclusions: Management with medroxyprogesterone may be an effective treatment to control the uterine bleeding associated with myomatosis. Their use could reduce the necessity of some hysterectomies.


REFERENCES

  1. Mandal D, Mandal S, Tapan KM, Parmanik S, Chandra SB. Role of hypogastric artery ligation in pelvic haemorrhage is still alive. Al Amenn J Med Sci 2013;6:12-16.

  2. García-López A, Martínez-Aguirre R, Hernández-Romero F, Naranjo-Gutiérrez A, Montes-Reyes J. Ligadura de arterias hipogástricas. Seguridad y eficacia de un programa de adiestramiento. Ginecol Obstet Mex 2001;69:443-448.

  3. Bellad MD. Internal Iliac Artery Ligation (IIAL): An uterus/ Life saving procedure. South Asian Federation of Obstetrics and Gynecology 2009;1:32-33.

  4. Dastur AE, Tank PD, Howard AK. Much beyond the stitch. J Obstet Gynecol India 2010;60:392-394.

  5. Hurtado-Estrada G, Cárdenas-González S, Barrón-Fuentes A, Cordero-Galera CA, y col. Ligadura de arterias hipogástricas, una cirugía heroica para evitar la mortalidad en ginecoobstetricia. Investigación Materno-infantil 2009;1:138-143.

  6. Serrano-Berrones MA. Comparación de dos técnicas quirúrgicas conservadoras para el tratamiento de la hemorragia obstétrica. RevEspMedQuir 2013;18:100-107.

  7. Ghanorro EP, Abedi HO, Isiavwe JO. Prophylactic internal iliac artery ligation in pelvic surgery. International Journal of Gynecology & Obstetrics 1999;65:307-309.

  8. Alemán-Ramirez PE, Suárez-González JA, Medina-Escobar E, Iglesias-Yera A. Ligadura de las arterias hipogástricas: una decisión oportuna en el sangrado de causa obstétrica. Medicentro 2005;9:1-6.

  9. McDonough PG, Emich JP, Schwarz RH. Interval before appearence of colaterals following hypogastric ligation. JACOG 1965;25:213-216.

  10. Joshi VM, Otiv SR, Majumder R, Nikam YA, Shirivastava M. Internal iliac artery ligation for arresting postpartum hemorrhage. DOI 10.1111/j. 1471-0528. 2006. 01235.x.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Ginecol Obstet Mex. 2015;83